The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 6
  • 1
    Philips, Trevor Michael
    Non Executive Director born in May 1961
    Individual (1 offspring)
    Officer
    2024-01-31 ~ now
    OF - Director → CIF 0
  • 2
    Clewlow, Paul Jonathan, Dr
    Chemist born in September 1959
    Individual (5 offsprings)
    Officer
    2024-01-31 ~ now
    OF - Director → CIF 0
  • 3
    Mr Per Frederik Alexander Kammerer
    Born in May 1968
    Individual (1 offspring)
    Person with significant control
    2021-05-19 ~ now
    PE - Ownership of voting rights - More than 25% but not more than 50% as a member of a firmCIF 0
  • 4
    Eldridge, William, Dr
    Interim Chief Executive Officer born in January 1969
    Individual (1 offspring)
    Officer
    2021-11-12 ~ now
    OF - Director → CIF 0
  • 5
    Leach, Renny Philip, Dr
    Director born in April 1956
    Individual (6 offsprings)
    Officer
    2008-01-24 ~ now
    OF - Director → CIF 0
  • 6
    Bengt Niclas Eriksson
    Born in May 1964
    Individual (1 offspring)
    Person with significant control
    2021-05-19 ~ now
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
Ceased 21
  • 1
    Radford, Ian Peter
    Individual (7 offsprings)
    Officer
    1998-05-28 ~ 2000-10-18
    OF - Secretary → CIF 0
  • 2
    Hillerbrand, Ulf, Doctor
    Consultant born in April 1958
    Individual
    Officer
    2002-12-09 ~ 2003-11-26
    OF - Director → CIF 0
  • 3
    Norfeldt, Per
    Psychiatrist born in November 1956
    Individual
    Officer
    2006-06-08 ~ 2010-12-31
    OF - Director → CIF 0
  • 4
    Ar Nominees Limited
    Individual
    Officer
    1998-05-28 ~ 1998-05-28
    OF - Nominee Director → CIF 0
  • 5
    Rand, Carolyn Ann
    Chief Executive Officer born in March 1964
    Individual (3 offsprings)
    Officer
    2014-12-01 ~ 2016-06-01
    OF - Director → CIF 0
    Rand, Carolyn Ann
    Individual (3 offsprings)
    Officer
    2014-11-28 ~ 2016-06-01
    OF - Secretary → CIF 0
  • 6
    Forsberg, Goran Olof Lorentz
    Corporate Vice President born in July 1963
    Individual
    Officer
    2011-09-26 ~ 2019-10-11
    OF - Director → CIF 0
  • 7
    Fitzgerald, Kevin John, Dr
    Ceo born in March 1964
    Individual (1 offspring)
    Officer
    2000-09-25 ~ 2010-01-31
    OF - Director → CIF 0
  • 8
    Lundin, Jan Olof Erling
    Director born in February 1946
    Individual
    Officer
    2001-02-08 ~ 2019-12-31
    OF - Director → CIF 0
    Mr Jan-olof Erling Lundin
    Born in February 1946
    Individual
    Person with significant control
    2017-06-01 ~ 2021-05-19
    PE - Has significant influence or controlCIF 0
  • 9
    Kerry, Simon, Dr
    Business Manager born in July 1963
    Individual (5 offsprings)
    Officer
    2000-09-25 ~ 2003-02-18
    OF - Director → CIF 0
  • 10
    Mcgibney, David, Dr
    Pharmaceutical Physician born in May 1953
    Individual (1 offspring)
    Officer
    2006-06-08 ~ 2008-02-13
    OF - Director → CIF 0
  • 11
    Ashburton Registrars Limited
    Individual
    Officer
    1998-05-28 ~ 1998-05-28
    OF - Nominee Secretary → CIF 0
  • 12
    Cochlovius, Bjoern, Dr
    Scientist born in October 1968
    Individual
    Officer
    2019-10-11 ~ 2021-05-31
    OF - Director → CIF 0
  • 13
    Burns, David Alexander
    Ceo born in March 1956
    Individual
    Officer
    2014-03-31 ~ 2017-07-25
    OF - Director → CIF 0
  • 14
    Powell, Steven John, Dr
    Director born in August 1961
    Individual (12 offsprings)
    Officer
    1998-05-28 ~ 2000-09-24
    OF - Director → CIF 0
  • 15
    Ullman, Christopher Graeme, Dr
    Chief Executive born in November 1968
    Individual (3 offsprings)
    Officer
    2014-09-24 ~ 2014-11-30
    OF - Director → CIF 0
  • 16
    Nixon, Anthony Michael
    Lawyer born in June 1957
    Individual (4 offsprings)
    Officer
    2000-10-18 ~ 2003-01-21
    OF - Director → CIF 0
    Nixon, Anthony Michael
    Individual (4 offsprings)
    Officer
    2000-10-18 ~ 2013-03-25
    OF - Secretary → CIF 0
  • 17
    Edwards, Anna-louise
    Individual
    Officer
    2016-06-02 ~ 2018-03-08
    OF - Secretary → CIF 0
  • 18
    Sceats, Emma Louise, Dr
    Ceo born in October 1978
    Individual (2 offsprings)
    Officer
    2018-09-18 ~ 2021-11-12
    OF - Director → CIF 0
  • 19
    Matthews, Kevin Roger Kenneth, Dr
    Company Director born in November 1963
    Individual (2 offsprings)
    Officer
    2009-09-30 ~ 2014-09-30
    OF - Director → CIF 0
  • 20
    Eriksson, Bengt Niclas
    Equity Investor born in May 1964
    Individual (1 offspring)
    Officer
    2003-11-26 ~ 2023-12-31
    OF - Director → CIF 0
  • 21
    Leanderson, Tomas, Professor
    Vp R&D born in April 1956
    Individual
    Officer
    2001-03-07 ~ 2010-01-01
    OF - Director → CIF 0
parent relation
Company in focus

ISOGENICA LIMITED

Previous name
PHARMACOPHORIX LIMITED - 2001-01-22
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Intangible Assets
2,747,801 GBP2023-12-31
2,474,134 GBP2022-12-31
Property, Plant & Equipment
86,953 GBP2023-12-31
134,738 GBP2022-12-31
Fixed Assets
2,834,754 GBP2023-12-31
2,608,872 GBP2022-12-31
Debtors
Current
653,213 GBP2023-12-31
395,194 GBP2022-12-31
Cash at bank and in hand
340,486 GBP2023-12-31
518,636 GBP2022-12-31
Current Assets
1,123,249 GBP2023-12-31
1,027,428 GBP2022-12-31
Creditors
Current, Amounts falling due within one year
-738,920 GBP2023-12-31
-519,858 GBP2022-12-31
Net Current Assets/Liabilities
384,329 GBP2023-12-31
507,570 GBP2022-12-31
Total Assets Less Current Liabilities
3,219,083 GBP2023-12-31
3,116,442 GBP2022-12-31
Creditors
Non-current, Amounts falling due after one year
0 GBP2023-12-31
-4,197 GBP2022-12-31
Net Assets/Liabilities
3,209,083 GBP2023-12-31
3,102,245 GBP2022-12-31
Equity
Called up share capital
9,066,592 GBP2023-12-31
9,066,592 GBP2022-12-31
Share premium
2,768,298 GBP2023-12-31
2,768,298 GBP2022-12-31
Retained earnings (accumulated losses)
-8,625,807 GBP2023-12-31
-8,732,645 GBP2022-12-31
Equity
3,209,083 GBP2023-12-31
3,102,245 GBP2022-12-31
Average Number of Employees
212023-01-01 ~ 2023-12-31
162022-01-01 ~ 2022-12-31
Intangible Assets - Gross Cost
Patents/Trademarks/Licences/Concessions
391,459 GBP2023-12-31
524,683 GBP2022-12-31
Development expenditure
2,882,366 GBP2023-12-31
2,443,191 GBP2022-12-31
Intangible Assets - Gross Cost
3,273,825 GBP2023-12-31
2,967,874 GBP2022-12-31
Intangible Assets - Accumulated Amortisation & Impairment
Patents/Trademarks/Licences/Concessions
309,882 GBP2023-12-31
409,606 GBP2022-12-31
Development expenditure
216,142 GBP2023-12-31
84,134 GBP2022-12-31
Intangible Assets - Accumulated Amortisation & Impairment
526,024 GBP2023-12-31
493,740 GBP2022-12-31
Intangible Assets - Increase From Amortisation Charge for Year
Patents/Trademarks/Licences/Concessions
36,038 GBP2023-01-01 ~ 2023-12-31
Development expenditure
132,008 GBP2023-01-01 ~ 2023-12-31
Intangible Assets - Increase From Amortisation Charge for Year
168,046 GBP2023-01-01 ~ 2023-12-31
Intangible Assets
Patents/Trademarks/Licences/Concessions
81,577 GBP2023-12-31
115,077 GBP2022-12-31
Development expenditure
2,666,224 GBP2023-12-31
2,359,057 GBP2022-12-31
Property, Plant & Equipment - Gross Cost
Land and buildings
31,644 GBP2023-12-31
31,644 GBP2022-12-31
Other
2,218,391 GBP2023-12-31
2,190,273 GBP2022-12-31
Property, Plant & Equipment - Gross Cost
2,250,035 GBP2023-12-31
2,221,917 GBP2022-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Land and buildings
31,644 GBP2023-12-31
31,644 GBP2022-12-31
Other
2,131,438 GBP2023-12-31
2,055,535 GBP2022-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
2,163,082 GBP2023-12-31
2,087,179 GBP2022-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Land and buildings
0 GBP2023-01-01 ~ 2023-12-31
Other
75,903 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
75,903 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment
Land and buildings
0 GBP2023-12-31
0 GBP2022-12-31
Other
86,953 GBP2023-12-31
134,738 GBP2022-12-31
Trade Debtors/Trade Receivables
Current
323,001 GBP2023-12-31
95,349 GBP2022-12-31
Amount of corporation tax that is recoverable
Current
122,643 GBP2023-12-31
148,718 GBP2022-12-31
Other Debtors
Amounts falling due within one year
207,569 GBP2023-12-31
151,127 GBP2022-12-31
Debtors
Current, Amounts falling due within one year
653,213 GBP2023-12-31
395,194 GBP2022-12-31
Debtors
782,763 GBP2023-12-31
508,792 GBP2022-12-31
Trade Creditors/Trade Payables
Current
183,572 GBP2023-12-31
147,121 GBP2022-12-31
Other Taxation & Social Security Payable
Current
47,159 GBP2023-12-31
42,073 GBP2022-12-31
Other Creditors
Current
508,189 GBP2023-12-31
330,664 GBP2022-12-31
Creditors
Current
738,920 GBP2023-12-31
519,858 GBP2022-12-31
Other Creditors
Non-current
0 GBP2023-12-31
4,197 GBP2022-12-31
Equity
Called up share capital
9,066,592 GBP2023-12-31
9,066,592 GBP2022-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
672,950 GBP2023-12-31
857,830 GBP2022-12-31

  • ISOGENICA LIMITED
    Info
    PHARMACOPHORIX LIMITED - 2001-01-22
    Registered number 03571781
    The Mansion Chesterford Research Park, Little Chesterford, Saffron Walden, Essex CB10 1XL
    Private Limited Company incorporated on 1998-05-28 (27 years 1 month). The company status is Active.
    The last date of confirmation statement was made at 2024-05-17
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.